Rhinology
Targeted biologics for chronic rhinosinusitis with nasal polyps: efficacy and safety comparison of eight monoclonal antibodies via network meta-analysis.
X Wang, P Ren, H He, J Zhao, Y Xin, H Wang, X Ren, K Zhu, J Chen
Published: 202610.4193/Rhin25.395
Abstract
BACKGROUND: Biologics targeting key type 2 inflammatory mediators (e.g., IL-4Rα, IgE, IL-5, TSLP) represent a novel therapeutic approach for chronic rhinosinusitis with nasal polyps (CRSwNP). This network meta-analysis (NMA) aimed to compare the effi…
Preview only. Read the full abstract at the source